Incubators for Infertility
(VILOCITY Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Benchtop Incubator, Multi-room Incubator, Tri-gas Incubator, Compact Incubator, Box Incubator, Conventional Incubator, Standard Incubator, Box CO2 Incubator for infertility?
Research shows that using incubators, like the CO2 gassing incubator, in IVF (in vitro fertilization) can maintain high fertilization rates of around 80% by providing a stable environment for embryos. This suggests that incubators are effective in supporting embryo development during fertility treatments.12345
Is the use of incubators for infertility treatment safe for humans?
How does the Benchtop Incubator treatment for infertility differ from other treatments?
The Benchtop Incubator treatment for infertility is unique because it provides a controlled microenvironment for embryo culture, maintaining stable conditions like temperature and CO2 levels, which are crucial for successful fertilization and embryo development. This approach simplifies the process and improves convenience compared to traditional methods, which may not offer the same level of environmental control.13457
What is the purpose of this trial?
The goal of this study is to determine if benchtop incubators improve the number of embryos making it to the blastocyst stage of development (about 4-6 days after fertilization) in people undergoing in vitro fertilization (IVF) treatment for their infertility.* Test the effectiveness of the benchtop incubator.* Determine if the number of embryos reaching the blastocyst stage of embryo development (the stage that the embryos are biopsied for PGT-A and frozen) is improved in the benchtop incubator compared to the box incubator.* Compare embryology outcomes between the two incubator types.* Investigate transfer and pregnancy outcomes.* Expand the knowledge surrounding the impact of the incubator on IVF outcomes. Patients will have their mature oocytes collected at the egg retrieval procedure split into two groups and randomized to be cultured in both incubator types.
Research Team
Thomas Molinaro, MD, MSCE
Principal Investigator
Reproductive Medicine Associates of New Jersey
Eligibility Criteria
This trial is for people undergoing IVF treatment due to infertility. Participants will have their mature oocytes collected and randomly assigned to two groups, each using a different type of incubator (benchtop or box) to culture the embryos.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Ovarian Stimulation and Oocyte Retrieval
Participants undergo ovarian stimulation and oocyte retrieval per routine
Randomization and Culture
Mature oocytes are split and randomized to be cultured in benchtop or box incubators
Blastocyst Assessment
Embryos are cultured to the blastocyst stage and assessed for blastulation rate and morphology
Follow-up
Participants are monitored for pregnancy outcomes and live birth rate
Treatment Details
Interventions
- Benchtop Incubator
- Box Incubator
Benchtop Incubator is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- In Vitro Fertilization (IVF)
- Embryo Culture
- In Vitro Fertilization (IVF)
- Embryo Culture
- In Vitro Fertilization (IVF)
- Embryo Culture
- In Vitro Fertilization (IVF)
- Embryo Culture
- In Vitro Fertilization (IVF)
- Embryo Culture
- In Vitro Fertilization (IVF)
- Embryo Culture
Find a Clinic Near You
Who Is Running the Clinical Trial?
Reproductive Medicine Associates of New Jersey
Lead Sponsor
CooperSurgical Inc.
Industry Sponsor